Search Results - "Grubbs, Gabrielle"
-
1
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
Published in Science translational medicine (01-07-2020)“…Multiple vaccine candidates against SARS-CoV-2 based on viral spike protein are under development. However, there is limited information on the quality of…”
Get more information
Journal Article -
2
Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination
Published in Nature communications (08-08-2022)“…There is limited knowledge on durability of neutralization capacity and antibody affinity maturation generated following two versus three doses of SARS-CoV-2…”
Get full text
Journal Article -
3
Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients
Published in Nature communications (22-02-2021)“…Hospitalized COVID-19 patients often present with a large spectrum of clinical symptoms. There is a critical need to better understand the immune responses to…”
Get full text
Journal Article -
4
Monoclonal antibodies targeting sites in respiratory syncytial virus attachment G protein provide protection against RSV-A and RSV-B in mice
Published in Nature communications (04-04-2024)“…Currently, only Palivizumab and Nirsevimab that target the respiratory syncytical virus (RSV) fusion protein are licensed for pre-treatment of infants…”
Get full text
Journal Article -
5
Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design
Published in Nature communications (17-09-2024)“…Limited knowledge exists on the quality of polyclonal antibody responses generated following Marburg virus (MARV) infection and its evolution in survivors. In…”
Get full text
Journal Article -
6
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
Published in Nature communications (01-12-2023)“…Emergence of highly transmissible Omicron subvariants led to increased SARS-CoV-2 infection and disease in children. However, minimal knowledge exists…”
Get full text
Journal Article -
7
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
Published in iScience (24-09-2021)“…Hyperimmune immunoglobulin (hCoV-2IG) generated from SARS-CoV-2 convalescent plasma (CP) are under evaluation in clinical trials. Here we explored the antibody…”
Get full text
Journal Article -
8
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex
Published in EBioMedicine (01-12-2021)“…Limited knowledge exists regarding antibody affinity maturation following mRNA vaccination in naïve vs. COVID-19 recovered individuals and potential sex…”
Get full text
Journal Article -
9
Evolution of the Antigenic Landscape in Children and Young Adults with COVID-19 and MIS-C
Published in Vaccines (Basel) (07-06-2024)“…There is minimal knowledge regarding the durability of neutralization capacity and level of binding antibody generated against the highly transmissible…”
Get full text
Journal Article -
10
Glycosylation of H4 influenza strains with pandemic potential and susceptibilities to lung surfactant SP-D
Published in Frontiers in molecular biosciences (13-06-2023)“…We recently reported that members of group 1 influenza A virus (IAV) containing H2, H5, H6, and H11 hemagglutinins (HAs) are resistant to lung surfactant…”
Get full text
Journal Article -
11
SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women
Published in EBioMedicine (01-03-2022)“…Limited knowledge exists in post-partum women regarding durability of SARS-CoV-2 vaccine-induced antibody responses and their neutralising ability against…”
Get full text
Journal Article -
12
Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients
Published in Clinical infectious diseases (29-01-2022)“…Abstract Convalescent plasma (CP) have been used for treatment of coronavirus disease 2019 (COVID-19), but their effectiveness varies significantly. Moreover,…”
Get full text
Journal Article -
13
Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis
Published in Clinical infectious diseases (21-04-2022)“…Our study demonstrates that children who developed SARS-CoV-2 vaccination-induced myocarditis and may not receive another vaccination, could be susceptible to…”
Get full text
Journal Article -
14
Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia
Published in Blood (05-05-2022)Get full text
Journal Article -
15
SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19
Published in Nature immunology (01-11-2021)“…There is limited understanding of the viral antibody fingerprint following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children…”
Get full text
Journal Article -
16
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron and Other Variants in Serum From Children With Vaccination-Induced Myocarditis
Published in Clinical infectious diseases (29-10-2022)“…Our study demonstrates that children who developed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination-induced myocarditis and may not…”
Get full text
Journal Article -
17
Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19
Published in Nature (London) (23-02-2023)“…Acute viral infections can have durable functional impacts on the immune system long after recovery, but how they affect homeostatic immune states and…”
Get full text
Journal Article -
18
Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine–Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019
Published in The Journal of infectious diseases (04-09-2022)“…Abstract Passive antibody immunotherapeutics directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are promising countermeasures for…”
Get full text
Journal Article -
19
mRNA vaccination induces persistent pharyngeal mucosal B cell responses to SARS-CoV-2 in children
Published in The Journal of immunology (1950) (01-05-2023)“…Abstract We recently reported that SARS-CoV-2 infection triggers robust, persistent adaptive immune responses in the tonsils and adenoids of children. However,…”
Get full text
Journal Article -
20
Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children
Published in Nature immunology (01-01-2023)“…Most studies of adaptive immunity to SARS-CoV-2 infection focus on peripheral blood, which may not fully reflect immune responses at the site of infection…”
Get full text
Journal Article